Literature DB >> 2881777

Control of aldosterone production by angiotensin II is mediated by two guanine nucleotide regulatory proteins.

W P Hausdorff, R D Sekura, G Aguilera, K J Catt.   

Abstract

The involvement of guanine nucleotide regulatory proteins in the steroidogenic response of the adrenal glomerulosa to angiotensin II (AII) was investigated by analyzing the effects of Bordetella pertussis toxin (PT) on several aspects of AII action. These included receptor binding, stimulation of aldosterone production and GTPase activity, inhibition of cAMP production, and attenuation of the aldosterone response at high angiotensin concentrations. Pretreatment of glomerulosa cells with PT abolished the inhibitory effects of both AII and somatostatin (SRIF) on ACTH-stimulated cAMP production. Under the same incubation conditions, the stimulation of aldosterone secretion by submaximal and maximal steroidogenic concentrations of AII was completely unaffected by the toxin. However, the attenuation of steroid responses seen with supramaximal concentrations of AII was abolished. In addition, the ability of SRIF to inhibit AII-stimulated steroid production was markedly reduced by PT treatment. The binding of [125I]AII to high affinity sites in intact cells and particulate fractions, and modulation of the binding by guanine nucleotides, were unaffected by toxin pretreatment, even under conditions where a 40-41K protein was completely ADP ribosylated. In contrast, the toxin substantially diminished the binding of [125I]Tyr0-SRIF to SRIF receptors in glomerulosa cells (by 50% after 5 h and by 90% after 20 h). These results indicate that Ni or a similar protein probably mediates the inhibition of cAMP formation by AII and the attenuation of the steroid response by high concentrations of AII as well as the inhibitory actions of SRIF in the adrenal glomerulosa cell. Furthermore, the lack of effect of PT on AII binding and stimulation of GTPase activity suggests the existence of an additional pertussis-insensitive guanine nucleotide-regulatory protein that is activated by lower concentrations of AII and mediates the stimulation of aldosterone production.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881777     DOI: 10.1210/endo-120-4-1668

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

Review 1.  Receptors and transduction mechanisms in anterior pituitary: primary cultures, transfected clonal cells and human tumor derived cells.

Authors:  A Enjalbert
Journal:  Cell Biol Toxicol       Date:  1992 Jul-Sep       Impact factor: 6.691

Review 2.  Acute and chronic regulation of aldosterone production.

Authors:  Namita G Hattangady; Lawrence O Olala; Wendy B Bollag; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2011-08-04       Impact factor: 4.102

3.  Angiotensin II potentiates adrenocorticotrophic hormone-induced cAMP formation in bovine adrenal glomerulosa cells through a capacitative calcium influx.

Authors:  M M Burnay; M B Vallotton; A M Capponi; M F Rossier
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

4.  Effects of angiotensin II on sustained outward currents in rat ventricular myocytes.

Authors:  Hiroyuki Matsuda; Yasutaka Kurata; Sunao Imanishi; Ryoichi Sato; Toshishige Shibamoto
Journal:  Pflugers Arch       Date:  2003-12-18       Impact factor: 3.657

5.  The site of action of Ca2+ in the activation of steroidogenesis: studies in Ca(2+)-clamped bovine adrenal zona-glomerulosa cells.

Authors:  C P Python; O P Laban; M F Rossier; M B Vallotton; A M Capponi
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

6.  Purification of an angiotensin II binding protein by using antibodies to a peptide encoded by angiotensin II complementary RNA.

Authors:  T S Elton; L D Dion; K L Bost; S Oparil; J E Blalock
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 7.  Signaling Interactions in the Adrenal Cortex.

Authors:  András Spät; László Hunyady; Gergő Szanda
Journal:  Front Endocrinol (Lausanne)       Date:  2016-02-29       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.